Stay updated on AK102 in HeFH: PCSK9 Inhibitor Clinical Trial
Sign up to get notified when there's something new on the AK102 in HeFH: PCSK9 Inhibitor Clinical Trial page.
Latest updates to the AK102 in HeFH: PCSK9 Inhibitor Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedRevision: v3.3.3 was added and references to HHS Vulnerability Disclosure and Revision: v3.3.2 were removed from the page footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%
- Check22 days agoNo Change Detected
- Check43 days agoChange DetectedThe changes are updates to the record history (Revision: v3.3.2 and v3.2.0) affecting only page metadata. They do not modify study details such as eligibility, outcomes, or recruitment; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check51 days agoChange DetectedRemoved the site-wide government funding notice about updates possibly not being up to date. This banner did not affect the trial record or its history.SummaryDifference0.8%
- Check65 days agoChange DetectedVersion 2023-03-01 adds an update to the Recruitment Status in the study record for NCT04173793.SummaryDifference0.1%
- Check94 days agoChange DetectedUpdated operating status notice and version to v3.2.0; removes v3.1.0.SummaryDifference13%
- Check101 days agoChange DetectedUpdated the page revision from v3.0.2 to v3.1.0, indicating a new software release or update a. No changes to core content, pricing, or stock are evident.SummaryDifference0.3%
Stay in the know with updates to AK102 in HeFH: PCSK9 Inhibitor Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AK102 in HeFH: PCSK9 Inhibitor Clinical Trial page.